Cerity Partners’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Cerity Partners’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	-$4K	–	1275
2022 Q2	$4K	Hold	200	–	–	﹤0.01%	1178
2022 Q1	$7K	Hold	200	–	–	﹤0.01%	934
2021 Q4	$7K	Hold	200	–	–	﹤0.01%	1015
2021 Q3	$15K	Hold	200	–	–	﹤0.01%	681
2021 Q2	$18K	Hold	200	–	–	﹤0.01%	707
2021 Q1	$23K	Buy	+200	New	+$22.2K	﹤0.01%	692

Other funds holding CSCI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cerity Partners's CSCI Position: Q3 2022 in Review

Cerity Partners sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 200 shares — an estimated $4K sold.

Cerity Partners first reported a position in CSCI in Q1 2021 and held it in 6 quarters. The position peaked at $23K in Q1 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Cerity Partners reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Cerity Partners sold 200 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $4K.
Cerity Partners first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Cerity Partners's COSCIENS Biopharma Inc. Common Stock position peaked at $23K in Q1 2021.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Cerity Partners's 13F filing for Q3 2022, filed 14 Nov 2022.